Cardiovascular disease (CVD) encompasses a myriad of pathologic developments in the
heart and peripheral vasculature. 1 These pathologies collectively represent the leading
cause of death globally as of 2016, and mortality is projected to increase by approximately 6
million by 2030, an alarming statistic especially in the face of substantially increasing health
care costs. 2 Therefore, it is imperative to take measures to improve patient outcomes for
individuals with CVD, an effort that is bolstered by advances in imaging used for diagnosis …